Journal ArticleOPEN ACCESS

Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?

  • Musto P
The Oncologist (2018) 23(5) 511-515
DOI: 10.1634/theoncologist.2018-0097
4Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.

Cite

CITATION STYLE

APA

Musto, P. (2018). Monoclonal Antibodies and Multiple Myeloma: All in All It’s Just Another Brick in the Wall? The Oncologist, 23(5), 511–515. https://doi.org/10.1634/theoncologist.2018-0097

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free